Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme

Por Lubanska, Dorota, Porter, Lisa
Publicado no Drugs R D (2017)

The atypical cell cycle regulator Spy1 suppresses differentiation of the neuroblastoma stem cell population

Por Lubanska, Dorota, Porter, Lisa A.
Publicado no Oncoscience (2014)

Atypical cell cycle control over neural cell fate

Por Lubanska, Dorota, Porter, Lisa A
Publicado no Cell Cycle (2014)

Spy1 Interacts with p27(Kip1) to Allow G(1)/S Progression

Por Porter, Lisa A., Kong-Beltran, Monica, Donoghue, Daniel J.
Publicado em 2003

Derivation of a novel G2 reporter system

Por Fidalgo da Silva, Elizabeth, Botsford, Sabrina, Porter, Lisa A.
Publicado no Cytotechnology (2014)

Exenatide once weekly: sustained improvement in glycemic control and cardiometabolic measures through 3 years

Por MacConell, Leigh, Pencek, Richard, Li, Yan, Maggs, David, Porter, Lisa
Publicado em 2013

Direct interactions with both p27 and Cdk2 regulate Spy1-mediated proliferation in vivo and in vitro

Por Al Sorkhy, Mohammad, Fifield, Bre-Anne, Myers, Dorothy, Porter, Lisa A.
Publicado no Cell Cycle (2016)

Randomized Comparison of Pramlintide or Mealtime Insulin Added to Basal Insulin Treatment for Patients With Type 2 Diabetes

Por Riddle, Matthew, Pencek, Richard, Charenkavanich, Supoat, Lutz, Karen, Wilhelm, Ken, Porter, Lisa
Publicado em 2009

The cyclin-like protein, SPY1, regulates the ERα and ERK1/2 pathways promoting tamoxifen resistance

Por Ferraiuolo, Rosa-Maria, Tubman, Janice, Sinha, Indrajit, Hamm, Caroline, Porter, Lisa Ann
Publicado no Oncotarget (2017)

Structural basis of divergent cyclin‐dependent kinase activation by Spy1/RINGO proteins

Por McGrath, Denise A, Fifield, Bre‐Anne, Marceau, Aimee H, Tripathi, Sarvind, Porter, Lisa A, Rubin, Seth M
Publicado no EMBO J (2017)

Contacts to solution-synthesized SnS nanoribbons: Dependence of barrier height on metal work function()

Por Hajzus, Jenifer R., Biacchi, Adam J., Le, Son T., Richter, Curt A., Hight Walker, Angela R., Porter, Lisa M.
Publicado no Nanoscale (2017)

The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer

Por Al Sorkhy, Mohammad, Ferraiuolo, Rosa-Maria, Jalili, Espanta, Malysa, Agnes, Fratiloiu, Andreea R, Sloane, Bonnie F, Porter, Lisa A
Publicado em 2012

Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2

Por Porter, Lisa A., Dellinger, Ryan W., Tynan, John A., Barnes, Elizabeth A., Kong, Monica, Lenormand, Jean-Luc, Donoghue, Daniel J.
Publicado em 2002

Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular prot...

Por Bazzi, Zainab A., Lanoue, Danielle, El-Youssef, Mouhanned, Romagnuolo, Rocco, Tubman, Janice, Cavallo-Medved, Dora, Porter, Lisa A., Boffa, Michael B.
Publicado no BMC Cancer (2016)

Exenatide at therapeutic and supratherapeutic concentrations does not prolong the QT(c) interval in healthy subjects

Por Darpö, Börje, Sager, Philip, MacConell, Leigh, Cirincione, Brenda, Mitchell, Malcolm, Han, Jenny, Huang, Wenying, Malloy, Jaret, Schulteis, Christine, Shen, Larry, Porter, Lisa
Publicado em 2013

DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks

Por Buse, John B., Drucker, Daniel J., Taylor, Kristin L., Kim, Terri, Walsh, Brandon, Hu, Hao, Wilhelm, Ken, Trautmann, Michael, Shen, Larry Z., Porter, Lisa E.
Publicado em 2010

Consequences of cardiac myocyte-specific ablation of K(ATP) channels in transgenic mice expressing dominant negative Kir6 subunits

Por Tong, XiaoYong, Porter, Lisa M., Liu, GongXin, Dhar-Chowdhury, Piyali, Srivastava, Shekhar, Pountney, David J., Yoshida, Hidetada, Artman, Michael, Fishman, Glenn I., Yu, Cindy, Iyer, Ramesh, Morley, Gregory E., Gutstein, David E., Coetzee, William A.
Publicado em 2006